New Zealand markets closed

PFE Jan 2024 47.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.2000+0.0600 (+5.26%)
As of 03:23PM EDT. Market open.
Full screen
Previous close1.1400
Expiry date2024-01-19
Day's range1.1100 - 1.2600
Contract rangeN/A
Open interest7.73k
  • Motley Fool

    3 Surprisingly Underrated Stocks to Buy in April

    Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) as opportunities that especially stand out. Prosper Junior Bakiny (Axsome Therapeutics): Last year, Axsome Therapeutics' share price doubled, partly due to the FDA approving its depression medicine Auvelity for use. The company's stock is down by 19% since the start of the year.

  • Motley Fool

    If You Invested $25,000 in Pfizer in 2020, This Is How Much You Would Have Today

    Investing in top COVID-19 vaccine maker Pfizer (NYSE: PFE) seems like it should have made you rich if you bought the stock in March 2020. On March 2, 2020, Pfizer's stock was selling for $33 a share. It would be nearly a year before Pfizer had an approved COVID-19 vaccine, which was produced in partnership with BioNTech.

  • Motley Fool

    Is It Time to Buy These Ultra-Cheap Dividend Stocks?

    High-quality dividend stocks can be a great way to tilt the odds in your favor as an investor. The core reason is that top-shelf dividend stocks generally have a long-standing shareholder base due to the reliability of their payouts.